Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T

Pain

Volumn 101, Issue 1-2, 2003, Pages 109-116

  Malmberg, Annika B ^a,c   Gilbert, Heather ^a   McCabe, R Tyler ^b   Basbaum, Allan I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cognetix Inc ^*  (United States)

^c ELAN PHARMACEUTICALS   (United States)

Author keywords

Antinociception; Ceutral sensitization; Conantokins; Cone snail venom derived peptides; Neuropathic pain

Indexed keywords

CONANTOKIN G; CONANTOKIN T; FORMALDEHYDE; FREUND ADJUVANT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OMEGA CONOTOXIN MVIIA; RECEPTOR SUBTYPE; SNAIL VENOM;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; EXPERIMENTAL MODEL; INFLAMMATION; LIGATION; MALE; MECHANICAL STIMULATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVE INJURY; NONHUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; SCIATIC NERVE; SNAIL; THERMAL STIMULATION; TREADMILL EXERCISE;

EID: 0037219288     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00303-2     Document Type: Article

References (60)

1. Bowersox S.S., Gadbois T., Singh T., Pettus M., Wang Y.X., Luther R.R. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J Pharmacol Exp Ther. 279:1996;1243-1249.
2. Boyce S., Wyatt A., Webb J.K., O'Donnell R., Mason G., Rigby M., Sirinathsinghji D., Hill R.G., Rupniak N.M. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology. 38:1999;611-623.
3. Carlton S.M., Zhou S., Coggeshall R.E. Evidence for the interaction of glutamate and NK1 receptors in the periphery. Brain Res. 790:1998;160-169.
4. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:1994;55-63.
5. Chaplan S.R., Malmberg A.B., Yaksh T.L. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther. 280:1997;829-838.
6. Chapman V., Suzuki R., Dickenson A.H. Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves L5-L6. J Physiol. 507:1998;881-894.
7. Chizh B.A., Reissmuller E., Schlutz H., Scheede M., Haase G., Englberger W. Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil. Neuropharmacology. 40:2001;212-220.
8. Coderre T.J., Melzack R. The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. J Neurosci. 9:1992;3671-3675.
9. Coderre T.J., Van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. Pain. 59:1994;353-359.
10. Davar G., Hama A., Deykin A., Vos B., Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res. 553:1991;327-330.
11. Dickenson A.H., Sullivan A.F. Differential effects of excitatory amino-acid antagonists on dorsal horn nociceptive neurons in the rat. Brain Res. 506:1990;31-39.
12. Di Luca M., Gardoni F., Finardi A., Pagliardini S., Cattabeni F., Battaglia G., Missale C. NMDA receptor subunits are phosphorylated by activation of neurotrophin receptors in PSD of rat spinal cord. NeuroReport. 12:2001;1301-1305.
13. Donevan S.D., McCabe R.T. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors. Mol Pharmacol. 3:2000;614-623.
14. Eide P.K., Jorum E., Stubhaug A., Bremnes J., Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 58:1994;347-354.
15. Fairbanks C.A., Schreiber K.L., Brewer K.L., Yu C.G., Stone L.S., Kitto K.F., Nguyen H.O., Grocholski B.M., Shoeman D.W., Kehl L.J., Regunathan S., Reis D.J., Yezierski R.P., Wilcox G.L. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci USA. 97:2000;10584-10589.
16. Fisher K., Coderre T.J., Hagen N.A. Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage. 20:2000;358-373.
17. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;141-167.
18. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 67:1980;313-316.
19. Jain K.K. An evaluation of intrathecal ziconotide for the treatment of chronic pain. Expert Opin Invest Drugs. 10:2000;2403-2410.
20. Klein R.C., Prorok M., Galdzicki Z., Castellino F.J. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. J Biol Chem. 276:2001;26860-26867.
21. Kristensen J.D., Svensson B., Gordh T. Jr. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain. 51:1992;249-253.
22. Laird J.M., Bennett G.J. An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy. J Neurophysiol. 69:1993;2072-2085.
23. Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M., Porreca F., Wilcox G.L. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain. 72:1997;253-260.
24. Leem J.W., Choi E.J., Park E.S., Paik K.S. N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor antagonists differentially suppress dorsal horn neuron responses to mechanical stimuli in rats with peripheral nerve injury. Neurosci Lett. 211:1996;37-40.
25. Ma Q.P., Hargreaves R.J. Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience. 101:2000;699-707.
26. Malmberg A.B., Basbaum A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain. 76:1998;215-222.
27. Malmberg A.B., Yaksh T.L. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N and P type channels inhibit formalin-induced nociception. J Neurosci. 14:1994;4882-4890.
28. Mao J., Price D.D., Hayes R.L., Lu J., Mayer D.J. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res. 598:1992;271-278.
29. Martin W.J., Malmberg A.B., Basbaum A.I. PKCγ contributes to a subset of the NMDA-dependent spinal circuits that underlie injury-induced persistent pain. J Neurosci. 21:2001;5321-5327.
30. Max M.B., Byas-Smith M.G., Gracely R.H., Bennett G.J. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol. 18:1995;360-368.
31. Minami T., Matsumura S., Okuda-Ashitaka E., Shimamoto K., Sakimura K., Mishina M., Mori H., Ito S. Characterization of the glutamatergic system for induction and maintenance of allodynia. Brain Res. 895:2001;178-185.
32. Momiyama A. Distinct synaptic and extrasynaptic NMDA receptors identified in dorsal horn neurones of the adult rat spinal cord. J Physiol. 523:(Pt 3):2000;621-628.
33. Neugebauer V., Lucke T., Grubb B., Schaible H.G. The involvement of N-methyl-D - aspartate (NMDA) and non-NMDA receptors in the responsiveness of rat spinal neurons with input from the chronically inflamed ankle. Neurosci Lett. 170:1994;237-240.
34. Nikolajsen L., Hansen C.L., Nielsen J., Keller J., Arendt-Nielsen L., Jensen T.S. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain. 67:1996;69-77.
35. Nishiyama T. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia. Can J Anaesth. 47:2000;693-698.
36. Olivera B.M., Rivier J., Clark C., Ramilo C.A., Corpuz G.P., Abogadie F.C., Mena E.E., Woodward S.R., Hillyard D.R., Cruz L.J. Diversity of Conus neuropeptides. Science. 249:1990;257-263.
37. Petralia R.S., Wang Y.X., Wenthold R.J. The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1. J Neurosci. 10:1994;6102-6120.
38. Portera-Cailliau C., Price D.L., Martin L.J. N-methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies. J Neurochem. 2:1996;692-700.
39. Prorok M., Castellino F.J. Structure-function relationships of the NMDA receptor antagonist conantokin peptides. Curr Drug Targets. 2:2001;313-322.
40. Puig S., Sorkin L.S. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain. 64:1996;345-355.
41. Quartaroli M., Carignani C., Dal Forno G., Mugnaini M., Ugolini A., Arban R., Bettelini L., Maraia G., Belardetti F., Reggiani A., Trist D.G., Ratti E., Di Fabio R., Corsi M. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D - aspartate receptor GV196771A. J Pharmacol Exp Ther. 290:1999;158-169.
42. Ren K., Hylden J.L., Williams G.M., Ruda M.A., Dubner R. The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain. 50:1992;331-344.
43. Rygh L.J., Svendsen F., Hole K., Tjolsen A. Increased spinal N-methyl-D - aspartate receptor function after 20 h of carrageenan-induced inflammation. Pain. 93:2001;15-21.
44. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
45. Sotgiu M.L., Biella G. Differential effects of MK-801, an N-methyl-D - aspartate non-competitive antagonist, on the dorsal horn neuron hyperactivity and hyperexcitability in neuropathic rats. Neurosci Lett. 283:2000;153-156.
46. Takaishi K., Eisele J.H. Jr, Carstens E. Behavioral and electrophysiological assessment of hyperalgesia and changes in dorsal horn responses following partial sciatic nerve ligation in rats. Pain. 66:1996;297-306.
47. Tal M., Bennett G.J. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. Neurosci Lett. 151:1993;107-110.
48. Tal M., Bennett G.J. Neuropathic pain sensations are differentially sensitive to dextrorphan. NeuroReport. 5:1994;1438-1440.
49. Tallarida R.J., Murray R.B. Manual of pharmacologic calculation with computer programs. 2nd ed. 1987;Springer, New York, NY.
50. Taniguchi K., Shinjo K., Mizutani M., Shimada K., Ishikawa T., Menniti F.S., Nagahisa A. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist. Br J Pharmacol. 122:1997;809-812.
51. Taylor B.K., Akana S.F., Peterson M.A., Dallman M.F., Basbaum A.I. Pituitary-adrenocortical responses to persistent noxious stimuli in the awake rat: endogenous corticosterone does not reduce nociception in the formalin test. Endocrinology. 139:1998;2407-2413.
52. Tölle T.R., Berthele A., Zieglgansberger W., Seeburg P.H., Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci. 12:1993;5009-5028.
53. Wegert S., Ossipov M.H., Nichols M.L., Bian D., Vanderah T.W., Malan T.P. Jr, Porreca F. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Pain. 71:1997;57-64.
54. Wei F., Wang G.D., Kerchner G.A., Kim S.J., Xu H.M., Chen Z.F., Zhuo M. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci. 4:2001;164-169.
55. Williams A.J., Dave J.R., Phillips J.B., Lin Y., McCabe R.T., Tortella F.C. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-Daspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. J Pharmacol Exp Ther. 294:2000;378-386.
56. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature. 306:1993;686-688.
57. Woolf C.J., Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
58. Yamamoto T., Yaksh T.L. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology. 77:1992;757-763.
59. Yamamoto T., Yaksh T.L. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain. 49:1992;121-128.
60. Yung K.K.L. Localization of glutamate receptors in dorsal horn of rat spinal cord. NeuroReport. 9:1998;1639-1644.